Labgenomics Co News
News
0
Ticker
084650.KQ
ISIN
KR7084650001
Labgenomics Co Eulerpool News
Labgenomics Co Stock News
Labgenomics Co is being monitored by journalists and investors worldwide. We gather the latest Labgenomics Co news here.
Labgenomics Co Stock Press Releases
Labgenomics Co regularly publishes news on the company's website that are relevant for investors.
Labgenomics Co News 2026
This page contains all current news, analysis and press releases for Labgenomics Co stock (084650.KQ, ISIN: KR7084650001). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Labgenomics Co.
Labgenomics Co Stock
Labgenomics Co LabGenomics Co., Ltd. generates revenue through the provision of in vitro diagnostic (IVD) products and services. The company offers general diagnostic check services, molecular diagnostic check services, and research and development services, alongside IVD products such as DNA chips and PCR kits. Its diagnostic services include examinations for breast cancer and colorectal cancer, while its biosensor solutions target point of care testing (POCT). Additionally, LabGenomics sells healthy food as part of its product portfolio. The primary buyers of LabGenomics' services are healthcare institutions requiring diagnostic support, including hospitals and clinics. The company's molecular diagnostic services and cancer examinations are particularly sought after by medical facilities focused on specialized testing. Healthcare providers also purchase its biosensor solutions for immediate testing at the point of care. LabGenomics' product segments include IVD services, IVD products like DNA chips and PCR kits, cancer examination services, and healthy food. The company's molecular diagnostic services and cancer testing are key revenue drivers, while its biosensor for POCT and healthy food offerings serve complementary market segments.